BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today a further expansion of its Research Grant program, adding $100,000 worth of reagents, cell culture tools and labware to support promising stem cell research.
"Even though the peak of the economic crisis appears to already have been reached, life scientists in the United States are still in desperate need for resources to keep their research projects alive," said Robert Balderas, Vice President of Biological Sciences, BD Biosciences. "BD Biosciences is proud to do its part to help advance some of the most promising stem cell and immunology research that could one day help cure or prevent disease."
When added to the existing $140,000 allocated to support immunology research, this new funding will bring the total annual support amount to $240,000, which will be distributed via 24 individual grants of BD Biosciences research reagents, cell culture tools and labware valued at $10,000 each.
The focus of the new stem cell research grants is to support the continuing study of embryonic, adult, and induced pluripotent stem cells to improve the understanding of both normal and disease processes. The program's immunology grants will support research in multicolor flow cytometry, cell signaling, cancer research, immune function, infectious diseases and neuroscience.
BD Life Sciences announces FDA clearance for BD MAX Enteric Parasite Panel